article thumbnail

Shorla gains FDA nod for first oral liquid version of Novartis' Gleevec

Fierce Pharma

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “am | Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of Novartis' cancer drug Gleevec. Dubbed Imkeldi, it becomes the first oral liquid form of imatinib.

FDA 293
article thumbnail

Germany considers banning the export of Novo Nordisk's Ozempic

Fierce Pharma

The craze is such that Germany’s drug regulator is considering banning the export of Ozempic, according to a report in Der Spiegel magazine. | How popular have Novo Nordisk’s semaglutide drugs become for weight loss in Europe?

299
299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Magazine-How delays derailed Covid-19 vaccination in Africa

Pharmaceutical Technology

The post Magazine-How delays derailed Covid-19 vaccination in Africa appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.

Pharma 110
article thumbnail

Magazine: CRISPR gene therapies cut through in 2023

Pharmaceutical Technology

The post Magazine: CRISPR gene therapies cut through in 2023 appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.

article thumbnail

Magazine: What Rishi Sunak can do for the UK pharma industry

Pharmaceutical Technology

The post Magazine: What Rishi Sunak can do for the UK pharma industry appeared first on Pharmaceutical Technology. All this, and the latest pharma industry news , comment, data, and analysis from GlobalData. Click here to view the latest issue of Pharmaceutical Technology Focus.

Pharma 93
article thumbnail

Chasing that ‘Time magazine cover potential’

PharmaVoice

Rami Elghandour was already retired. Then CAR-T specialist Arcellx lured him back into the industry to try to change the world.

98
article thumbnail

Magazine: Pharma’s path to Net Zero: Targeting Scope 3 emissions

Pharmaceutical Technology

In this issue: Pharma’s efforts to curb Scope 3 emissions, understanding European Pharmaceutical legislation, and looking back at the pharma industry’s performance in 2023.

Pharma 98